NCT04879225

Brief Summary

Menthol cigarettes comprise almost one-third of the United States (US) market share and are disproportionately smoked by racial minorities. Tobacco control policies targeting menthol flavoring in tobacco could have significant public health outcomes, especially among black smokers. One key challenge of tobacco regulation is weighing the risks and benefits of potential policies across different populations (i.e., users and non-users). Tension arises between policies intended to prevent adolescent and young adult (AYA) tobacco initiation and those intended to reduce harm among current tobacco users. The availability of menthol e-liquids may be important for encouraging menthol cigarette smokers to switch to e- cigarettes, but mint e-liquids, which are appealing to AYA, may be unnecessary to facilitate switching. Including mint e-liquids in flavor bans but allowing menthol e-liquids to remain on the market as potential substitution products for menthol smokers may be an optimal policy approach. The study team is proposing a lab study and field assessment to determine how including menthol and mint e-liquids in e-liquid flavor bans or sales restrictions affects tobacco product purchasing and use among menthol cigarette smokers. At lab sessions, participants will complete the Experimental Tobacco Marketplace (ETM) task, a behavioral economics task in which they receive account balances to an online store and can buy menthol cigarettes at escalating costs or buy e-liquids, non-menthol cigarettes, or nicotine replacement gum at fixed costs. They will complete the task under four marketplace conditions: (1) only tobacco e-liquids available, (2) menthol and tobacco e-liquids available, (3) menthol, mint, and tobacco e-liquids available, and (4) tobacco, menthol, mint, fruit, dessert. During a field assessment, product choice is validated by assessing use of products purchased during the ETM task. This proposal will inform policy-makers about the impact banning menthol and mint e-liquids will have on facilitating menthol cigarette smokers switching to e-cigarettes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

May 10, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

June 21, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2022

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

June 26, 2024

Completed
Last Updated

June 26, 2024

Status Verified

April 1, 2022

Enrollment Period

1.5 years

First QC Date

April 13, 2021

Results QC Date

December 22, 2023

Last Update Submit

June 21, 2024

Conditions

Keywords

smokingmentholmintvapingmenthol ban

Outcome Measures

Primary Outcomes (4)

  • Total Amount of Combusted Tobacco Purchased

    Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.

    Day 3

  • Total Amount of Combusted Tobacco Purchased

    Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.

    Day 4

  • Total Amount of Combusted Tobacco Purchased

    Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.

    Day 5

  • Total Amount of Combusted Tobacco Purchased

    Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.

    Day 6

Secondary Outcomes (1)

  • Total Amount of E-liquid Purchased

    Day 3, Day 4, Day 5, Day 6

Other Outcomes (12)

  • Total Amount of Non-menthol Cigarettes

    Day 3, Day 4, Day 5, Day 6

  • Total Amount of Tobacco E-liquid Purchased

    Day 3, Day 4, Day 5, Day 6

  • Total Amount of Menthol E-liquid Purchased

    Day 3, Day 4, Day 5, Day 6

  • +9 more other outcomes

Study Arms (4)

Intervention 1: Fruit, dessert, mint, menthol, tobacco

EXPERIMENTAL

All participants receive all interventional e-liquid flavors on separate days.

Behavioral: All e-liquid flavors

Intervention 2: Mint, menthol, and tobacco

EXPERIMENTAL

All participants receive all interventional e-liquid flavors on separate days.

Behavioral: Mint, Menthol and Tobacco e-liquids

Intervention 3: Menthol and Tobacco

EXPERIMENTAL

All participants receive all interventional e-liquid flavors on separate days.

Behavioral: Menthol and Tobacco e-liquids

Intervention 4: Only tobacco

EXPERIMENTAL

All participants receive all interventional e-liquid flavors on separate days.

Behavioral: Tobacco e-liquids

Interventions

Marketplace includes tobacco flavored e-liquids

Intervention 4: Only tobacco

Marketplace includes menthol and tobacco flavored e-liquids

Intervention 3: Menthol and Tobacco

Marketplace includes mint, menthol and tobacco flavored e-liquids

Intervention 2: Mint, menthol, and tobacco

Marketplace includes fruit, dessert, mint, menthol and tobacco flavored e-liquids

Intervention 1: Fruit, dessert, mint, menthol, tobacco

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • + years of age
  • Self-report smoking at least 5 cigarettes per day for the past year
  • Self-report smoking menthol cigarette brands \> 80% of the time
  • Breathe carbon monoxide (CO) level \> 8 ppm Willingness to use other tobacco products during the study
  • Speak, comprehend, and read English sufficiently to complete study procedures
  • Have home access to a computer or tablet with a web camera and internet access

You may not qualify if:

  • Currently seeking treatment to quit smoking
  • Self-reported serious medical or psychiatric condition(s) including cardiovascular and chronic respiratory diseases
  • Body temperature \> 100.4 F
  • Cold, flu or Novel Coronavirus (COVID-19) symptoms including fever, cough, and runny nose in the past 30 days
  • Currently pregnant, breastfeeding or intending to become pregnant for the duration of the study or unwilling to agree to use adequate protection to avoid pregnancy
  • CO reading \> 80 ppm
  • Enrollment stratum (Non-Hispanic, white or Black/African American)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Health Sciences

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Cigarette SmokingVapingSmoking

Interventions

MentholSPEN protein, human

Condition Hierarchy (Ancestors)

Tobacco SmokingBehaviorTobacco Use

Intervention Hierarchy (Ancestors)

CyclohexanolsHexanolsFatty AlcoholsAlcoholsOrganic ChemicalsCyclohexane MonoterpenesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsMonoterpenesTerpenesLipids

Limitations and Caveats

Several recruitment methods were utilized to identify participants including flyers, Craigslist and contracting with a clinical research recruitment agency. All methods yielded participants but ultimately were not enough to meet our enrollment goal of 80 participants. We experienced a significant uptick in the number of enrolled participants in the final months of the study. We attribute this to the temporal change that has resulted from a return to normal activities after the COVID-19 pandemic.

Results Point of Contact

Title
Emily Harwood
Organization
Wake Forest University School of Medicine

Study Officials

  • Rachel Denlinger, PhD, MPH

    Wake Forest Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SEQUENTIAL
Model Details: Participants will experience four marketplace conditions that differ in the availability of flavored e-liquids.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2021

First Posted

May 10, 2021

Study Start

June 21, 2021

Primary Completion

December 29, 2022

Study Completion

December 29, 2022

Last Updated

June 26, 2024

Results First Posted

June 26, 2024

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations